Eagle Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-318,354
| Closed | -$37.7M | – | 619 |
|
|
2022
Q1 | $37.7M | Sell |
318,354
-15,162
| -5% | -$1.8M | 0.19% | 152 |
|
|
2021
Q4 | $46.1M | Sell |
333,516
-1,946
| -0.6% | -$269K | 0.2% | 153 |
|
|
2021
Q3 | $46.6M | Sell |
335,462
-54,260
| -14% | -$7.54M | 0.21% | 159 |
|
|
2021
Q2 | $37.8M | Sell |
389,722
-14,160
| -4% | -$1.37M | 0.16% | 179 |
|
|
2021
Q1 | $27.6M | Sell |
403,882
-154,904
| -28% | -$10.6M | 0.12% | 210 |
|
|
2020
Q4 | $47.9M | Sell |
558,786
-92,379
| -14% | -$7.92M | 0.27% | 136 |
|
|
2020
Q3 | $41.1M | Buy |
651,165
+6,386
| +1% | +$403K | 0.21% | 164 |
|
|
2020
Q2 | $44.7M | Sell |
644,779
-96,940
| -13% | -$6.72M | 0.25% | 144 |
|
|
2020
Q1 | $25.2M | Sell |
741,719
-4,830
| -0.6% | -$164K | 0.16% | 189 |
|
|
2019
Q4 | $40.6M | Sell |
746,549
-237,786
| -24% | -$12.9M | 0.2% | 188 |
|
|
2019
Q3 | $41.1M | Buy |
+984,335
| New | +$41.1M | 0.21% | 170 |
|